Results 291 to 300 of about 95,754 (365)

Changing the Flow: How EUS‐Guided Drainage is Reshaping the Management of Distal Malignant Biliary Obstruction

United European Gastroenterology Journal, Volume 14, Issue 1, February 2026.
ABSTRACT Endoscopic ultrasound‐guided biliary drainage (EUS‐BD) has evolved from a rescue therapy into a viable alternative to endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous drainage for distal malignant biliary obstruction (dMBO).
Jeska A. Fritzsche, Inge de Vries, Jeanin E. van Hooft, Rogier P. Voermans, Roy L. J. van Wanrooij   +4 more
wiley   +1 more source

Peripheral basophil activation: A hidden player in the immunopathogenesis of primary biliary cholangitis. [PDF]

World J Hepatol
Han HQ, Bao JM, Deng W, Guo WF, Li YF, Zheng WQ, Liu HF.   +6 more
europepmc   +1 more source

Severe Hepatic Adverse Event Induced by Anti‐HER2 Therapy in Breast Cancer: A Case of Successful Immunotherapy With Baricitinib

ACR Open Rheumatology, Volume 8, Issue 2, February 2026.
Yufei Li, Yifan Wang, Miao Shao, Jing He
wiley   +1 more source

Beyond Ursodeoxycholic Acid: A Comprehensive Review of Second-Line Agents in Primary Biliary Cholangitis. [PDF]

Cureus
Lakshmanan V, Morris L.
europepmc   +1 more source

Prediction of Hepatocellular Carcinoma and Other Liver‐Related Events in Chronic Hepatitis B Patients With Metabolic Dysfunction or Metabolic Dysfunction‐Associated Steatotic Liver Disease

Alimentary Pharmacology &Therapeutics, Volume 63, Issue 3, Page 374-382, February 2026.
This study evaluated the performance of the PAGE‐B score in HCC risk among CHB patients with metabolic dysfunction or MASLD. The PAGE‐B score effectively stratified HCC risk in both MASLD and non‐MASLD patients, especially in those without cirrhosis, where low scores were linked to negligible 5‐year HCC risk. ABSTRACT Introduction Metabolic dysfunction
Lesley A. Patmore, Ivana Carey, Jordan J. Feld, Willem P. Brouwer, Keyur Patel, Maria Buti, Pieter Honkoop, Douwe F. Postma, Hans Blokzijl, Özgur. M. Koc, Eva van Oorschot, Kosh Agarwal, Marc van der Valk, Faydra I. Lieveld, Mai Kilany, Matthijs Kramer, Joep de Bruijne, Mark A. A. Claassen, Bettina E. Hansen, Robert A. de Man, Harry L. A. Janssen, R. Bart Takkenberg, Milan J. Sonneveld   +22 more
wiley   +1 more source

Pediatric liver transplantation with cyclosporine and steroids [PDF]

, 1984
Gartner, JC, Iwatsuki, S, Malatack, JJ, Shaw, BW, Starzl, TE, Urbach, AH, Zitelli, BJ   +6 more
core  

High biochemical remission rates in patients with primary biliary cholangitis treated with "triple" anticholestatic therapy. [PDF]

Hepatol Commun
Cançado GGL, Chen B, Cameron M, Houri I, Leung KK, Gulamhusein AF, Hansen B, Hirschfield GM.   +7 more
europepmc   +1 more source

Comparison of pathological features of patients with antibody-negative and positive primary biliary cholangitis. [PDF]

BMC Gastroenterol
Liu HL, Liu X, Hu YF, Wang XX, Zhang Y, Wang L, Li SS, Bao YJ, Zheng SW, Xiong QF, Zhong YD, Liu DX, Huang P, Feng XN, Zeng WQ, Zhang CY, Zhang K, Yang YF.   +17 more
europepmc   +1 more source

Soluble CD163 as a Biomarker of Liver Fibrosis and Inflammation in Liver Transplant Recipients

Clinical Transplantation, Volume 40, Issue 2, February 2026.
ABSTRACT Background and Aims Post liver transplantation (LT) inflammation and fibrosis are clinical challenges that may affect long‐term outcomes. We aimed to investigate sCD163 as a biomarker of liver fibrosis in LT recipients and compare it with the Fibrosis 4 (FIB‐4) score and FibroScan.
Emilie Høegholm Ernst Lauridsen, Rasmus Hvidbjerg Gantzel, Moises Alberto Suarez‐Zdunek, Mette Bak Nielsen, Allan Rasmussen, Susanne Dam Nielsen, Henning Grønbæk, Gerda Elisabeth Villadsen   +7 more
wiley   +1 more source

Identification of Differentially Expressed Genes and Molecular Pathways Involved in Primary Biliary Cholangitis Using RNA-Seq. [PDF]

Genes (Basel)
Yang M, Shen X, Fu H, Lu J, Li F.
europepmc   +1 more source